Serum chloride was a strong and independent predictor of mortality at 6 months after a pulmonary arterial hypertension diagnosis.
The "egg-and-banana" sign is a valid computed tomography marker of pulmonary hypertension.
At the end of 6 months, the rate of VTE recurrence was 4% among rivaroxaban patients vs 11% in the dalteparin arm (hazard ratio [HR] 0.43, 95% CI: 0.19 to 0.99).
A protocolized study including initiation of VA-ECMO may reduce mortality in patients with massive PE.
Ischemic heart disease and kidney dysfunction were identified as 2 comorbidities that may affect outcomes in idiopathic pulmonary arterial hypertension.
Stem cell therapy targeting right ventricular failure may help improve pulmonary circulation in pulmonary arterial hypertension.
The sNDA is accompanied by results from the MERIT-1 trial, a Phase 2 randomized, placebo-controlled, double-blind study which assessed the efficacy, safety and tolerability of macitentan 10mg in 80 patients with inoperable CTEPH.
Walking a distance of >400 meters in the 6-minute walk test was associated with a reduced risk for pulmonary arterial hypertension-related death or hospitalization.
In patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension, targeted pharmacologic treatment was associated with an increase in achieved therapeutic goals.
A 64-year-old man with chronic obstructive pulmonary disease, diabetes, chronic kidney disease, and morbid obesity seeks preoperative approval for femoral popliteal bypass surgery.
Pulmonary hypertension in heart failure with preserved ejection fraction is associated with mortalityApril 18, 2018
Pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF) is common in patients undergoing right heart catheterization. Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are predictors of mortality and cardiac hospitalizations in PH-HFpEF.
Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.
N-terminal-pro brain natriuretic peptide may be a useful biomarker for both mortality and respiratory exacerbations in pediatric patients with pulmonary hypertension.
Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.
A 32-year-old woman presents to the emergency department with complaints of dyspnea on exertion and near syncopal episodes.
Nearly two-thirds of phosphodiesterase-5 inhibitor prescriptions are inconsistent with pulmonary hypertension guidelines.
Patients with pulmonary arterial hypertension may be better identified with the use of a claims-based algorithm that includes ICD-9-CM codes, electronic medical records, and more.
Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are associated with mortality in patients with pulmonary hypertension and heart failure with preserved ejection fraction.
Hemodynamic markers of pulmonary hypertension in heart failure with preserved ejection fraction are associated with mortalityMarch 20, 2018
Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are predictors of mortality and cardiac hospitalizations in pulmonary hypertension associated with heart failure with preserved ejection fraction.
There was an increased risk for acute respiratory distress syndrome after undergoing cardiac surgery during influenza season.
Several drugs may demonstrate different safety profiles and side effects that warrant a change in treatment for individuals with pulmonary hypertension.
Monitoring the plasma BNP level in individuals with pulmonary arterial hypertension may aid clinicians in therapeutic decision-making and overall prediction of 5-year survival rate.
The prevalence of pulmonary embolism is low in patients presenting to the emergency department with syncope.
Researchers discovered an association between global pulmonary vascular remodeling and pulmonary hypertension in patients with heart failure.
In a postmarketing surveillance study, ambrisentan demonstrated tolerability and potential effectiveness for pulmonary arterial hypertension treatment.
Patients diagnosed with an intermediate-risk pulmonary embolism may be able to start oral anticoagulation therapy after completing 72 hours of heparin therapy during hospitalization.
Smoking-related changes in lung microbiota may increase the risk for acute respiratory distress syndrome in patients after severe trauma.
Exercise intolerance is a hallmark symptom of pulmonary arterial hypertension.
The diagnostic value of bronchoalveolar lavage in idiopathic pulmonary fibrosis is evaluated.
A case study is of worsening dyspnea in a patient with COPD is presented.
The Cardiology Advisor Articles
- Oral Anticoagulant Effective in Recurrent VTE Prevention in Cancer Patients
- Updated Blood Pressure Guidelines Identify Children With Previously Underestimated Risk
- Egg-and-Banana Sign Has High Specificity for Pulmonary Hypertension Diagnosis
- Hyoscyamine Helps in Afib With Slow Ventricular Response
- AHA: Annual OB/GYN Appointment Can Benefit Women's Heart Health
- Tenecteplase Appears Superior to Alteplase After Ischemic Stroke
- Oxygen Therapy in Acute MI Not Associated With Clinical Benefit
- Hyoscyamine Helps in Afib With Slow Ventricular Response
- Deep Venous Thrombosis Ultrasound Protocol Recommendations
- Transforming Congenital Heart Disease Outcomes With 3D Printing
- International Liaison Committee on Resuscitation Identifies CPR Knowledge Gaps
- Coronary Heart Disease Mortality Often Attributed to Sudden Arrhythmic Death
- Doctors May Avoid Performing PCI Due to Public Reporting
- Best Practices Developed for Use of EHR to Enhance Patient Care
- FDA Approves Epoetin Alfa Biosimilar Retacrit